Global University Venturing

Mary Albertson is the new director for Georgia Tech’s Office of Technology Licensing, joining from University of Utah’s Pivot Center.

Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.

An economic downturn is a great time to back startups on better terms. But investors should be careful of the tricky politics of down rounds.

Klarna's 83% drop in valuation to $6.7bn is the most visible harbinger of a buy now, pay later sector suffering from defaults and competition - some from the same corporates investing there.

The number of crypto and token funding rounds is still climbing but the overall volume of capital in these deals has fallen sharply.

Corporates are still investing in startups but valuations have fallen dramatically. Some areas such as China and healthcare have been hit hard.

Being an early customer for startups — rather than investing in them — can increase the amount of technology a corporate can bring in 10x.

Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.

Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.

The debt finance deal gives FTX the chance to buy crypto management tool developer BlockFi for up to $240m - less than 10% of its last valuation - and the news should be making equity investors nervous.

We've condensed down three days of talks, networking and demos at the GCVI Summit in Monterey into these insights.